PatientsVille.com Logo

Torvast Side Effects

PatientsVille

Common Torvast Side Effects


The most commonly reported Torvast side effects (click to view or check a box to report):

Rhabdomyolysis (9)
Myalgia (8)
Rash (6)
Gamma-glutamyltransferase Increased (6)
Pruritus (5)
Hepatitis Cholestatic (5)
Blood Creatine Phosphokinase Increased (5)
Hypertransaminasaemia (4)
Asthenia (4)
Vomiting (4)
Hepatitis Acute (3)
Abdominal Pain Upper (3)
Blood Alkaline Phosphatase Increased (3)
Jaundice (3)
Weight Decreased (3)
Liver Disorder (3)
Respiratory Failure (3)
Myopathy (3)
Necrosis (2)
Oliguria (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Torvast Side Effects Reported to FDA



Torvast Side Effect Report#9752757
Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Myalgia
This is a report of a 37-year-old male patient (weight: NA) from IT, suffering from the following health symptoms/conditions: infarction, who was treated with Torvast (dosage: 80 Mg, 1x/day, start time:
Sep 16, 2012), combined with:
  • Cardioaspirin (100 Mg, Unk)
  • Efient (10 Mg, Unk)
  • Triatec (1.25 Mg, Unk)
  • Cardicor (2.5 Mg, Unk)
  • Eskim (2000 Mg, Unk)
and developed a serious reaction and side effect(s): Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Myalgia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Torvast treatment in male patients, resulting in Blood Creatine Phosphokinase Increased side effect.
Torvast Side Effect Report#9696409
Pruritus, Blood Creatine Phosphokinase Increased, Rhabdomyolysis
This report suggests a potential Torvast Pruritus side effect(s) that can have serious consequences. A 39-year-old male patient (weight: NA) from IT was diagnosed with the following symptoms/conditions: dyslipidaemia,diabetes mellitus and used Torvast (dosage: Unk) starting NS. After starting Torvast the patient began experiencing various side effects, including: Pruritus, Blood Creatine Phosphokinase Increased, RhabdomyolysisAdditional drugs used concurrently:
  • Metformin (500 Mg, 3x/day)
The patient was hospitalized. Although Torvast demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pruritus, may still occur.
Torvast Side Effect Report#9686768
Aggression, Agitation, Insomnia
This Aggression problem was reported by a pharmacist from IT. A 91-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: hypercholesterolaemia,hypothyroidism. On
Aug 07, 2013 this consumer started treatment with Torvast (dosage: 10 Mg, Daily). The following drugs were being taken at the same time:
  • Eutirox (50 Ug, Daily)
When using Torvast, the patient experienced the following unwanted symptoms/side effects: Aggression, Agitation, InsomniaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Aggression, may become evident only after a product is in use by the general population.
Torvast Side Effect Report#9681583
Hepatic Enzyme Increased, Hepatic Failure, Intracardiac Thrombus
This Hepatic Enzyme Increased side effect was reported by a physician from IT. A 86-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Torvast (drug dosage: 40 Mg, Daily), which was initiated on
Oct 06, 2013. Concurrently used drugs:
  • Metformin Hcl (3000 Mg, Daily)
  • Plavix (75 Mg, Daily)
  • Levopraid (37.5 Mg, Unk)
  • Fosfomycina Ratiopharm (1 Df, Unk)
.After starting to take Torvast the consumer reported adverse symptoms, such as: Hepatic Enzyme Increased, Hepatic Failure, Intracardiac ThrombusThese side effects may potentially be related to Torvast. The patient was hospitalized.
Torvast Side Effect Report#9629305
Rhabdomyolysis, Colitis, Plantar Fasciitis, Tendonitis
This is a report of a 72-year-old male patient (weight: NA) from IT, suffering from the following health symptoms/conditions: coronary artery disease, who was treated with Torvast (dosage: 10 Mg, 1x/day, start time:
Jan 01, 2004), combined with:
  • Acetylsalicylic Acid (100 Mg, Unk)
  • Pantoprazole (1 Df, Unk)
  • Glibomet (3 Df, Unk)
  • Lantus (25 Iu, Unk)
  • Pritorplus (1 Df, Unk)
and developed a serious reaction and side effect(s): Rhabdomyolysis, Colitis, Plantar Fasciitis, Tendonitis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Torvast treatment in male patients, resulting in Rhabdomyolysis side effect. The patient was hospitalized.
Torvast Side Effect Report#9512497
Diabetes Mellitus
This report suggests a potential Torvast Diabetes Mellitus side effect(s) that can have serious consequences. A 85-year-old male patient (weight: NA) from IT was diagnosed with the following symptoms/conditions: hyperlipidaemia,hypertension and used Torvast (dosage: 10 Mg, Daily) starting
Apr 17, 2012. After starting Torvast the patient began experiencing various side effects, including: Diabetes MellitusAdditional drugs used concurrently:
  • Altiazem (180 Mg, Daily)
  • Soldesam (4 Mg, Unk)
  • Keppra (1 Df, Unk)
  • Monocinque (20 Mg, Unk)
  • Clexane (1 Df, Unk)
  • Zestril (20 Mg, Unk)
The patient was hospitalized. Although Torvast demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Diabetes Mellitus, may still occur.
Torvast Side Effect Report#9437608
Retinal Haemorrhage
This Retinal Haemorrhage problem was reported by a physician from IT. A 50-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: hypercholesterolaemia. On
Nov 03, 2012 this consumer started treatment with Torvast (dosage: 10 Mg, Daily). The following drugs were being taken at the same time: NA. When using Torvast, the patient experienced the following unwanted symptoms/side effects: Retinal HaemorrhageAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Retinal Haemorrhage, may become evident only after a product is in use by the general population.
Torvast Side Effect Report#9437026
Loss Of Consciousness
This Loss Of Consciousness side effect was reported by a physician from IT. A 93-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Torvast (drug dosage: 1 Df, Daily), which was initiated on
Apr 15, 2013. Concurrently used drugs:
  • Cordarone (1 Df, Daily)
  • Coumadin (10 Milligram(s);daily (2 Dose Form Daily))
  • Micardis (1 Df, 1x/day)
.After starting to take Torvast the consumer reported adverse symptoms, such as: Loss Of ConsciousnessThese side effects may potentially be related to Torvast.
Torvast Side Effect Report#9396235
Asthenia, Muscle Atrophy, Myalgia
This is a report of a 67-year-old female patient (weight: NA) from IT, suffering from the following health symptoms/conditions: prophylaxis, who was treated with Torvast (dosage: 40 Mg, 1x/day, start time:
Apr 13, 2013), combined with: NA. and developed a serious reaction and side effect(s): Asthenia, Muscle Atrophy, Myalgia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Torvast treatment in female patients, resulting in Asthenia side effect. The patient was hospitalized.
Torvast Side Effect Report#9355496
Pancreatitis, Presyncope
This report suggests a potential Torvast Pancreatitis side effect(s) that can have serious consequences. A 73-year-old male patient (weight: NA) from IT was diagnosed with the following symptoms/conditions: hyperlipidaemia and used Torvast (dosage: 10 Mg, Daily) starting
Jan 08, 2013. After starting Torvast the patient began experiencing various side effects, including: Pancreatitis, PresyncopeAdditional drugs used concurrently:
  • Pantoprazole (20 Mg, Unk)
  • Allopurinol (300 Mg, Unk)
  • Ventolin (Unk)
  • Gaviscon (Unk)
The patient was hospitalized. Although Torvast demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pancreatitis, may still occur.
Torvast Side Effect Report#9330166
Dysuria, Erythema, Pruritus
This Dysuria problem was reported by a physician from IT. A 46-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Mar 01, 2013 this consumer started treatment with Torvast (dosage: 80 Mg, Daily). The following drugs were being taken at the same time:
  • Effient (10 Mg)
  • Congescor (1.25 Mg)
  • Pantorc (20 Mg)
When using Torvast, the patient experienced the following unwanted symptoms/side effects: Dysuria, Erythema, PruritusAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Dysuria, may become evident only after a product is in use by the general population.
Torvast Side Effect Report#9320454
Myalgia, Abdominal Pain Upper, Paraesthesia
This Myalgia side effect was reported by a physician from IT. A 50-year-old male patient (weight:NA) experienced the following symptoms/conditions: hypercholesterolaemia.The patient was prescribed Torvast (drug dosage: 80 Mg, 1x/day), which was initiated on
Mar 25, 2013. Concurrently used drugs: NA..After starting to take Torvast the consumer reported adverse symptoms, such as: Myalgia, Abdominal Pain Upper, ParaesthesiaThese side effects may potentially be related to Torvast. The patient was hospitalized.
Torvast Side Effect Report#9320068
Anaemia, Myalgia, Rhabdomyolysis, Renal Failure
This is a report of a 84-year-old patient (weight: NA) from IT, suffering from the following health symptoms/conditions: arteriosclerosis, who was treated with Torvast (dosage: 40 Mg, Daily, start time:
May 15, 2013), combined with:
  • Norvasc
  • Antra
  • Cardioaspirin
  • Cefamezin ^pharmacia-upjohn^
  • Lortaan
  • Clexane
  • Zyloric
and developed a serious reaction and side effect(s): Anaemia, Myalgia, Rhabdomyolysis, Renal Failure after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Torvast treatment in patients, resulting in Anaemia side effect. The patient was hospitalized.
Torvast Side Effect Report#9308099
Hypersensitivity
This report suggests a potential Torvast Hypersensitivity side effect(s) that can have serious consequences. A 75-year-old male patient (weight: NA) from IT was diagnosed with the following symptoms/conditions: coronary artery disease and used Torvast (dosage: 80 Mg, 1x/day) starting
Apr 28, 2013. After starting Torvast the patient began experiencing various side effects, including: HypersensitivityAdditional drugs used concurrently:
  • Ranexa (750 Mg, 1x/day)
  • Plavix (Unk)
  • Irbesartan (Unk)
  • Pantoprazole (Unk)
Although Torvast demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Hypersensitivity, may still occur.
Torvast Side Effect Report#9290555
Gamma-glutamyltransferase Increased, Hypertransaminasaemia
This Gamma-glutamyltransferase Increased problem was reported by a physician from IT. A 69-year-old patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Jan 21, 2013 this consumer started treatment with Torvast (dosage: 20 Mg Daily). The following drugs were being taken at the same time: NA. When using Torvast, the patient experienced the following unwanted symptoms/side effects: Gamma-glutamyltransferase Increased, HypertransaminasaemiaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Gamma-glutamyltransferase Increased, may become evident only after a product is in use by the general population.
Torvast Side Effect Report#9289345
Renal Failure, Rhabdomyolysis, Thrombocytopenia, Epistaxis, Hypotension, Hyponatraemia, White Blood Cell Count Decreased, Red Blood Cell Count Decreased
This Renal Failure side effect was reported by a pharmacist from IT. A 48-year-old male patient (weight:NA) experienced the following symptoms/conditions: arteriosclerosis.The patient was prescribed Torvast (drug dosage: 40 Mg, Daily), which was initiated on
Jan 01, 2010. Concurrently used drugs: NA..After starting to take Torvast the consumer reported adverse symptoms, such as: Renal Failure, Rhabdomyolysis, Thrombocytopenia, Epistaxis, Hypotension, Hyponatraemia, White Blood Cell Count Decreased, Red Blood Cell Count DecreasedThese side effects may potentially be related to Torvast. The patient was hospitalized.
Torvast Side Effect Report#9242350
Hypercreatinaemia, Blood Creatine Phosphokinase Increased
This is a report of a 77-year-old male patient (weight: NA) from IT, suffering from the following health symptoms/conditions: hypercholesterolaemia, who was treated with Torvast (dosage: 10 Mg, Daily, start time:
May 10, 2010), combined with:
  • Dilatrend (Unk)
  • Monoket (Unk)
  • Plavix (Unk)
  • Ascriptin (Unk)
  • Amiodar (Unk)
  • Mirapexin (Unk)
  • Enapren (Unk)
  • Minitran (Unk)
and developed a serious reaction and side effect(s): Hypercreatinaemia, Blood Creatine Phosphokinase Increased after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Torvast treatment in male patients, resulting in Hypercreatinaemia side effect. The patient was hospitalized.
Torvast Side Effect Report#9224693
Gamma-glutamyltransferase Increased
This report suggests a potential Torvast Gamma-glutamyltransferase Increased side effect(s) that can have serious consequences. A 86-year-old female patient (weight: NA) from IT was diagnosed with the following symptoms/conditions: hypercholesterolaemia and used Torvast (dosage: 40 Mg, 1x/day) starting
Mar 05, 2012. After starting Torvast the patient began experiencing various side effects, including: Gamma-glutamyltransferase IncreasedAdditional drugs used concurrently:
  • Dilatrend
  • Duoplavin
  • Eutirox
The patient was hospitalized. Although Torvast demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Gamma-glutamyltransferase Increased, may still occur.
Torvast Side Effect Report#9147444
Intentional Overdose, Intentional Self-injury, Electrocardiogram Qt Prolonged, Hypotension, Syncope
This Intentional Overdose problem was reported by a physician from IT. A 41-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: intentional overdose. On
Feb 25, 2013 this consumer started treatment with Torvast (dosage: 35 Df, Unit Doses Total). The following drugs were being taken at the same time:
  • Depakin Chrono (40 Df, Unit Doses Total)
  • Cipralex (70 Df, Unit Doses Total)
When using Torvast, the patient experienced the following unwanted symptoms/side effects: Intentional Overdose, Intentional Self-injury, Electrocardiogram Qt Prolonged, Hypotension, SyncopeThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Intentional Overdose, may become evident only after a product is in use by the general population.
Torvast Side Effect Report#9129151
Hypokalaemia, Myalgia, Rhabdomyolysis, Hypomagnesaemia, Blood Parathyroid Hormone Decreased
This Hypokalaemia side effect was reported by a physician from IT. A 80-year-old male patient (weight:NA) experienced the following symptoms/conditions: dyslipidaemia,essential hypertension.The patient was prescribed Torvast (drug dosage: 40 Mg, Daily), which was initiated on 2008. Concurrently used drugs:
  • Norvasc (10 Mg, Unk)
  • Enapren (5 Mg, Unk)
  • Cardioaspirin (100 Mg, Unk)
  • Amaryl (2 Mg, Unk)
  • Avodart (0.5 Mg, Unk)
  • Xatral (10 Mg, Unk)
  • Omeprazolo Eg (20 Mg, Unk)
.After starting to take Torvast the consumer reported adverse symptoms, such as: Hypokalaemia, Myalgia, Rhabdomyolysis, Hypomagnesaemia, Blood Parathyroid Hormone DecreasedThese side effects may potentially be related to Torvast. The patient was hospitalized.
Torvast Side Effect Report#9031102
Hepatotoxicity, Gamma-glutamyltransferase Increased, Transaminases Increased, Blood Alkaline Phosphatase Increased
This is a report of a 80-year-old female patient (weight: NA) from IT, suffering from the following health symptoms/conditions: hypercholesterolaemia, who was treated with Torvast (dosage: 40 Mg, Daily, start time:
Nov 01, 2012), combined with:
  • Ticlopidine (Unk)
  • Zarelis (Unk)
  • Folina (Unk)
and developed a serious reaction and side effect(s): Hepatotoxicity, Gamma-glutamyltransferase Increased, Transaminases Increased, Blood Alkaline Phosphatase Increased after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Torvast treatment in female patients, resulting in Hepatotoxicity side effect.
Torvast Side Effect Report#8943428
Myositis
This report suggests a potential Torvast Myositis side effect(s) that can have serious consequences. A 41-year-old male patient (weight: NA) from IT was diagnosed with the following symptoms/conditions: hypercholesterolaemia and used Torvast (dosage: 20 Mg, Daily) starting
Jan 01, 2008. After starting Torvast the patient began experiencing various side effects, including: MyositisAdditional drugs used concurrently: NA.The patient was hospitalized. Although Torvast demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Myositis, may still occur.
Torvast Side Effect Report#8926621
Eczema, Erythema, Impetigo, Pain, Pruritus
This Eczema problem was reported by a physician from IT. A 85-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Nov 04, 2012 this consumer started treatment with Torvast (dosage: Unk). The following drugs were being taken at the same time:
  • Cumadin (Unk)
  • Zyloric (300 Ug, Daily)
  • Clexane (Unk)
  • Cardioaspirin (Unk)
  • Rocefin (Unk)
When using Torvast, the patient experienced the following unwanted symptoms/side effects: Eczema, Erythema, Impetigo, Pain, PruritusThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Eczema, may become evident only after a product is in use by the general population.
Torvast Side Effect Report#8924806
Gamma-glutamyltransferase Increased, Jaundice, Hypertransaminasaemia
This Gamma-glutamyltransferase Increased side effect was reported by a physician from IT. A 81-year-old female patient (weight:NA) experienced the following symptoms/conditions: hyperlipidaemia.The patient was prescribed Torvast (drug dosage: 20 Mg, 1x/day), which was initiated on
Nov 20, 2010. Concurrently used drugs:
  • Eutirox (50 Ug, Unk)
  • Cardicor (1.25 Mg, Unk)
  • Pritor (80 Mg, Unk)
  • Lanoxin (0.125 Mg, Unk)
.After starting to take Torvast the consumer reported adverse symptoms, such as: Gamma-glutamyltransferase Increased, Jaundice, HypertransaminasaemiaThese side effects may potentially be related to Torvast. The patient was hospitalized.
Torvast Side Effect Report#8909826
Hepatitis Acute
This is a report of a 78-year-old female patient (weight: NA) from IT, suffering from the following health symptoms/conditions: hypercholesterolemia, who was treated with Torvast (dosage: 40 Mg, Daily, start time:
Jan 01, 2009), combined with:
  • Metoprolol
  • Combisartan
  • Noradox
  • Zyloric
and developed a serious reaction and side effect(s): Hepatitis Acute after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Torvast treatment in female patients, resulting in Hepatitis Acute side effect.


1 of 4 


The appearance of Torvast on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.


Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Torvast reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Torvast Side Effects

    Did You Have a Torvast Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Torvast for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Torvast Safety Alerts, Active Ingredients, Usage Information

    NDC0179-0141
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameATORVASTATIN CALCIUM
    NameATORVASTATIN CALCIUM
    Dosage FormTABLET, FILM COATED
    RouteORAL
    On market since20131105
    LabelerKAISER FOUNDATION HOSPITALS
    Active Ingredient(s)ATORVASTATIN CALCIUM
    Strength(s)80
    Unit(s)mg/1
    Pharma ClassHMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

    More About Torvast

    Side Effects reported to FDA: 80

    Torvast safety alerts: 2012 2010 2003

    Reported deaths: 4

    Reported hospitalizations: 47

    Atorvastatin Calcium Tablets by Ranbaxy Inc.: Recall - Presence of Foreign Substance

    [Posted 11/28/2012]

    AUDIENCE: Pharmacy, Patient, Health Professional

    ISSUE: On November 9, 2012, Ranbaxy Inc. initiated a voluntary recall of 41 affected lots of Atorvastatin Calcium Tablets (10 mg, 20 mg and 40 mg) which is a solid oral dosage form, to the retail level. The Company is taking this voluntary action as a precautionary measure due to the fact that we cannot exclude the possibility that the affected lots may contain very small glass particles resembling a fine grain of sand (less than 1 mm in size). Because of the size of the particles which may be present in the affected lots it is unlikely to cause a significant safety concern. However, the possibility of adverse experiences arising primarily due to physical irritation cannot be ruled out.

    BACKGROUND: The product is used to lower blood cholesterol and is packaged in plastic bottles, as 90 and 500 tablets per bottle. The affected lots of Atorvastatin Calcium Tablets and their respective NDC code, expiration date information can be found in the Firm Press Release. The recall does not affect or relate to the 80 mg dosage strength of Atorvastatin Calcium Tablets.

    RECOMMENDATION:  Consumers should immediately contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

    • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.
       

    [11/29/2012 - Questions and Answers - FDA]

    [11/29/2012 - FDA Statement - FDA]

    [11/28/2012 - Firm Press Release - Ranbaxy Inc.]

    Latest Torvast clinical trials